Flavonoids and their glycosides form a large group of polyphenolic compounds which are widely distributed in plants. 2, 3) Animals depend on plants for flavonoids as they are unable to biosynthesize them.
flavour and processing characteristics to many foods (fruits and vegetables) and drinks (tea, wine). 7) So far, over 4000 flavonoid derivatives have been identified and numerous beneficial health effects including, anti-inflammatory, [8] [9] [10] antiviral 11) and anti-cancer 8, 12, 13) properties have been reported. Some epidemiological studies have also demonstrated that the intake of flavonoids reduced the risk of cardiovascular diseases. 8, [14] [15] [16] Most of the pharmacological activities could be attributed to their ability to inhibit certain enzymes and to their oxygen free radical scavenging and iron chelating capabilities. 17) The antioxidant properties are suggested to be due to the number and arrangement of their phenolic hydroxyl groups. 18) It has been shown that 3-hydroxy-, 7-hydroxy-and 5-hydroxyflavones have hypochlorite scavenging activity with 3-hydroxyflavone showing the greatest effect. 19) Depending on the concentration and the reaction conditions, flavonoids could act as antioxidants as well as prooxidants. 17) Toxicity of some flavonoids has been attributed to their prooxidant behavior. Hence, careful examination of flavonoids for their behavior in varying reaction conditions has to be carried out before being considered for therapeutic uses. 17) Although in vitro experiments have shown that flavonoids possess a wide range of biological activities, their overall function in vivo has to be clarified. It has been observed that only aglycones and flavonoid glucosides are absorbed in the small intestine. 18) They are then metabolized rapidly to methylated, glucuronidated or sulphated metabolites in the jejunal and ileal parts of the small intestine. After metabolism in the intestine, the flavonoids are further metabolized in the liver to yield various conjugated forms. The reactions include methylation, sulphation and glucuronidation. Conjugation is essentially a detoxification process in which the compounds are made to eliminate by way of bile and urine by increasing their hydrophilic character. 20) The unabsorbed flavonoids undergo further metabolism by the bacterial enzymes in the colon. 21) Using animal models, human trials and in vitro fermentation experiments, it was shown that the intestinal microorganisms are greatly responsible for catabolism and scission of the flavonoid. Scission of the flavonoid structure depends on their hydroxylation pattern. 21) Absence of hydroxyl groups in the B-ring for example, prevents ring scission. In vitro metabolism studies of flavonoids using rat liver microsomes showed that the B-ring is the main structural moiety that undergoes biotransformation. B-rings with a single hydroxyl group at C-4Ј or none at all get hydroxylated by microsomal cytP 450 enzymes. 21) It has been demonstrated that the bioavailability of flavonoids in general is low due to limited absorption and rapid elimination. For example, the peak plasma concentrations of citrus flavonoids was less than 1 mM/l. 20) It is also known that they are rapidly and extensively bio-transformed into metabolites which do not always have the same biological activities of the parent compounds. 22) As seen in in vitro antioxidant experiments, most circulating flavonoids are actually the metabolites rather than the original compounds indicating that the active compounds may not be the dietary flavonoids. 22, 23) Thus, to ascertain the role of flavonoids as biologically active compounds it is essential to know the chemical nature and the bioavailability of the absorbed forms. Being predictive models for mammalian drug metabolism, microorganisms are used to establish the metabolic fate of biologically active compounds. [24] [25] [26] This procedure gives significant amounts of metabolites for complete structure elucidations and for further pharmacological evaluations. Reports on the microbial transformation of flavonoids are relatively few 27) and thus, we initiated a program to investigate the microbial metabolism of some selected flavonoids. Here we report the transformation of 3-hydroxyflavone (1) by Beauveria bassiana (ATCC 13144) and 7-hydroxyflavone (2) by Nocardia species, Aspergillus alliaceus (ATCC 10060) and Beauveria bassiana (ATCC 7159).
Results and Discussion
Initial screening of compounds 1 and 2 was carried out with forty organisms using the standard two stage procedure. 24 28) The sugar part was further confirmed by comparing the 13 C resonances with those reported for the corresponding carbons in a similar 4-O-methylglucopyranoside. 29) The remaining signals of the NMR spectra confirmed the structure of the unchanged aglycone moiety. The assignment of signals of compound 4 was based on 1 H-1 H correlation spectroscopy (COSY), heteronuclear multiple-quantum coherence (HMQC), HMBC spectra. Consequently, metabolite 4 was identified as the new com-
One of the minor metabolites (9) (3 mg, 0.75% yield) of flavonol (1) had a molecular formula of C 22 H 28 O 8 by HR-ESI-MS. This was an increase of six mass units as compared to 4. It was reflected in the 1 H-NMR spectrum, where additional peaks were observed at d 4.17 (1H), 3.50 (1H), 3.44 (1H) and 2.20 (2H). The IR spectrum showed a broad absorption at 3319 cm Ϫ1 indicating the presence of hydroxyl group(s). The absence of a peak due to carbonyl in the 13 C-NMR spectrum indicated the absence of a carbonyl group in the molecule. The NMR spectra of compound 9 however, showed close resemblance to those of 4 with respect to the A and B rings and the sugar moiety. NMR data also suggested 3-O-glucosylation as in 4. However, the disappearance of peaks due to C-2 (d 159. Metabolite 5 (57.2 3% yield) with a molecular formula of C 16 H 12 O 3 as determined by HR-ESI-MS, 13 C-NMR and DEPT data, was isolated as a white solid. Strong absorption peaks at 2925 (C-H), 1633 (br) cm Ϫ1 (CϭC) and (CϭO) were observed in the IR spectrum. The NMR spectra of 5 resembled those of 2 in all aspects except that the hydroxyl group at C-7 has been methylated. Analysis of high-resolution NMR spectra and a comparison with reported data 31) confirmed that 5 was 7-methoxyflavone.
HR-ESI-MS, 13 C-NMR and DEPT data suggested a molecular formula C 15 31) confirmed that compound 6 was 4Ј,7-dihydroxyflavone.
Metabolite 7 (186.9 mg, 21% yield) showed a molecular mass of 414 comprising of a 7-hydroxyflavone (m/z 238) and an O-methylglucopyranosyl moiety (m/z 178). The exact molecular mass was consistent with a molecular formula of C 22 It is unclear whether the 4-O-methylglucopyranosyl moiety in the metabolites, 4, 7 and 8 originated from the medium or the fungus.
Conclusion
In the present study, four metabolites of 3-hydroxyflavone (1) produced by B. bassiana (ATCC 13144) and four of 7-hydroxyflavone (2), converted by Nocardia species (NRRL 5646), A. alliaceus (ATCC 10060) and B. bassiana (ATCC 7159) were isolated. Whilst all the products of flavone 2 were characterized, only two metabolites of compound 1 were identified. The other two were isolated in quantities insufficient for full structure elucidations. However, one was assigned a tentative structure (9) using available spectroscopic data. The transformations observed in this study are the results of functionalization (Phase I) and conjugation (Phase II) reactions. As detected in previous transformation experiments with most microorganisms, 27) we observed hydroxylation of the B-ring at C-4Ј in metabolites, 3, 6 and 8. Relatively poor yields of the three metabolites could be due to decreased binding of flavones 1 and 2 to the enzymes responsible for hydroxlation. 27) Both flavones yielded the conjugated products, 4, 5, 7, 8 and 9. The formation of hydroxylation and conjugation products in this study are paralleled in mammals [32] [33] [34] indicating the use of microbes to mimic mammalian metabolism. Microbes usually form glucosides rather than glucuronides as occurs in mammals. 35) As reported, conjugation are the most common final step reactions in mammalian metabolism of intact flavonoids. 20) Metabolite 9 is a cleavage product of flavone 1. 36) Previous work on microbial transformation of flavonoids also reported some cleavage products. 32) Cleavage of flavonoids in mammals has been shown to be brought about by the colonic microflora. 20) The metabolites obtained are in sufficient quantities for biological as well as further chemical studies. Compounds 4, 7 and 8 are described as new compounds
Experimental
General Experimental Procedures UV spectra were run on a Hewlett Packard 8452A diode array spectrometer. IR spectra were recorded in CHCl 3 using an ATI Mattson Genesis series FTIR spectrophotometer. Organisms and Metabolism Microorganisms (37) from the collection of the National Center for Natural Products Research, University of Mississippi, were used in the preliminary screening experiments to identify organisms capable of metabolizing 1 and 2. Medium a, 24) consisting of dextrose, 20 g; NaCl, 5 g; K 2 HPO 4 , 5 g; bacto-peptone (Difco Labs, Detroit, MI, U.S.A.), 5 g and yeast extract (Difco Labs), 5 g per liter of distilled water was used in all fermentation experiments based on a two-stage procedure. 24) Initial screening was performed in 125 ml Erlenmeyer flasks (125 ml) containing 25 ml medium-a. Compounds 1 and 2 were added separately in dimethylformamide (0.5 mg/ml) solution to 24 h old stage II cultures. Incubation was carried out at room temperature for a period of 14 d on a rotary shaker (New Brunswick Model G10-21) at 100 rpm. Monitoring of the samples was carried out at 7-d intervals, using precoated Si gel 60 F 254 TLC plates (E. Merck) with EtOAc-hexane (3 : 2) as the solvent system. Spots on TLC were visualized by UV light (254, 365 nm) and also with the help of the spray reagent, p-anisaldehyde. Five 2 l flasks, each containing 100 mg of substrate dispersed in 500 ml of medium-a were used for preparative scale fermentation of 3-hydroxyflavone (1) with B. bassiana. Similarly, 100 mg of 7-hydroxyflavone (2) in each of five 2 l flasks containing 500 ml of the same medium were used with each of Nocardia species, A. alliaceous and B. bassiana. The combined culture filtrates were extracted with EtOAc/ (Me) 2 CHOH-EtOAc (2 : 9) and the solvents were evaporated. The residues obtained were subjected to partition or column chromatography. Wherever needed, further purification was carried out by preparative thin layer (Silica gel 60 F 254 ) chromatography. Substrate and culture controls were run simultaneously with the above experiments.
24)

Microbial Transformation of 3-Hydroxyflavone (1) by B. bassiana
The combined culture filtrates were extracted with EtOAc and the solvent was evaporated to dryness. The resulting brown solid was column chromatographed over silica gel (Si gel 230-400 mesh: E. Merck, 30 g, column diameter: 20 mm.) with CHCl 3 gradually enriched with MeOH. Purification of the metabolites was by repeated column and preparative layer chromatography (EtOAc-hexane, 3 : 2). Four compounds were isolated. Only structures of metabolites 3 (5 mg) and 4 (20 mg) were fully characterized as the other two compounds were in quantities insufficient for full structure elucidation.
However, one of the minor compounds was assigned a tentative chalcanol structure (9) (2 mg).
3,4Ј-Dihdroxyflavone (3) Microbial Transformation of 7-Hydroxyflavone (2) by A. alliaceus (ATCC 10060) The EtOAc/(Me) 2 CHOH-EtOAc (2 : 9) extract of the combined culture media and the EtOAc extract of the MeOH extract of the mycelium showed a similar TLC profile. Partition chromatography (Saki High HPCPC: LLB-M) however, was effected on the extracts using hexaneEtOAc-(Me) 2 
